Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
The Journal of Antimicrobial Chemotherapy|December 5, 2013
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapyS Lambert-Niclot, C Charpentier, A Storto, et al.Journal of Medical Virology|March 25, 2008
National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutationC Delaugerre, P Flandre, A G Marcelin, et al.Annales De Dermatologie Et De Venereologie|January 2, 2018
Anaplastic Kaposi's sarcoma: 5 cases of a rare and aggressive type of Kaposi's sarcomaM Chapalain, G Goldman-Lévy, N Kramkimel, et al.The Journal of Antimicrobial Chemotherapy|July 31, 2018
Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West AfricaD B Fofana, M d'Almeida, S Lambert-Niclot, et al.The Journal of Antimicrobial Chemotherapy|May 29, 2016
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patientsL Bocket, G Peytavin, E K Alidjinou, et al.The Journal of Antimicrobial Chemotherapy|June 12, 2016
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemiaC Katlama, C Soulié, F Caby, et al.Archives of Dermatology|December 15, 2000
Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipientsS Barete, V Calvez, C Mouquet, et al.The Journal of Antimicrobial Chemotherapy|July 25, 2014
Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept studyS Seang, S Fourati, Y Keita, et al.The Journal of Antimicrobial Chemotherapy|July 10, 2020
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrationsR Palich, M Wirden, G Peytavin, et al.The Journal of Antimicrobial Chemotherapy|April 9, 2008
Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavirB Masquelier, K L Assoumou, D Descamps, et al.Pageof 7